Source-Cell Storage Systems for Allogeneic Cell Therapy Products: Comparison of the Regulatory Systems in Target Countries-Reference-Cited by-同舟云学术

Source-Cell Storage Systems for Allogeneic Cell Therapy Products: Comparison of the Regulatory Systems in Target Countries

Published:2023-06-30 Issue:1 Volume:1 Page:57-74
ISSN:2983-0745
Container-title:Research in Clinical Pharmacy
language:en
Short-container-title:Research in Clinical Pharmacy

Author:

Khan Chanjoo¹,Shin Hocheol¹,Kim Eunyoung¹²^ORCID

Affiliation:

1. Department of Regulatory Science and Pharmaceutical Industry, Chung-Ang University, Seoul, Korea

2. Clinical Data Analysis, Evidence-Based Clinical Research Laboratory, Department of Health Science & Clinical Pharmacy, College of Pharmacy, Chung-Ang University, Seoul, Korea

Funder

National Research Foundation of Korea

Ministry of Science and ICT

Ministry of Education

Publisher

Asian Conference on Clinical Pharmacy

Link

http://pdf.medrang.co.kr/RCP/2023/001/rcp-1-1-57.pdf

Reference84 articles.

1. Scientific considerations for the regulatory evaluation of cell therapy products

2. Ministry of Food and Drug Safety. Act No. 17472, Act on the safety and support for advanced regenerative medicine and advanced biopharmaceuticals [Internet]. Sejong: Ministry of Government Legislation; 2020 [cited 2023 Jan 31]. Available from: https://www.law.go.kr/lsSc.do?section=&menuId=1&subMenuId=15&tabMenuId=81&eventGubun=060101&query=%EC%B2%A8%EB%8B%A8%EB%B0%94%EC%9D%B4%EC%98%A4%EC%9D%98%EC%95%BD%ED%92%88#undefined

3. Latest status of the clinical and industrial applications of cell sheet engineering and regenerative medicine

4. Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis

5. Current status of biology, bioengineering, and therapeutic potential of stem cells